Muscle flaps in the treatment of osteomyelitis of the lower extremity

被引:30
作者
Gonzalez, MH
Weinzweig, N
机构
[1] Cook Cty Hosp, Div Orthoped Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Orthoped Surg, Chicago, IL USA
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2005年 / 58卷 / 05期
关键词
D O I
10.1097/01.TA.0000162733.72969.D5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Thirty three consecutive patients with chronic osteomyelitis and deficient soft tissue coverage treated with a muscle flap from 1991-1998 were reviewed retrospectively. Osteomyelitis was diagnosed by positive bone cultures and radiographic changes consistent with osteomyelitis. Osteomyelitis was divided into localized < 50% diameter : 24 patients and diffuse > 50% diameter or infected nonunion: 9 patients. The average age was 38 (18-74). The cause of the osteomyelitis was open fracture 23, closed fracture and open reduction internal fixation 5, gun-shot wound 3, burn 1, and chronic venous stasis ulcer 1. Localized osteomyelitis was treated with saucerization and coverage with a free or rotational muscle flap. Pan-diaphyseal osteomyelitis was treated with a complete diaphysectomy in 3, and wide saucerization in 2. Twenty three patients were treated with a free flap and 10 with a rotational flap. A reconstructive success was considered a limb that allowed full weight bearing with a stable wound, no drainage and no recurrence of infection. Patients were evaluated for risk factors: malnutrition, renal or liver failure, alcohol abuse, immune deficiency, chronic hypoxia, malignancy, diabetes, age over 70, steroid therapy, tobacco abuse, or drug abuse. Patients were followed an average of 34 months (12-58) after surgery. A reconstructive success was achieved in 91% (20/22) of patients with local osteomyelitis and in 56% (5/9) of patients with diffuse osteomyelitis (p < 0.05). A reconstructive success was achieved in 88% (7/8) patients with no risk factors and in 78% (18/23) of patients with one or more risk factors (not significant p = 0.05).
引用
收藏
页码:1019 / 1023
页数:5
相关论文
共 50 条
[41]   COMPARISON OF FREE ANTEROLATERAL THIGH FLAPS AND FREE MUSCLE-MUSCULOCUTANEOUS FLAPS IN SOFT TISSUE RECONSTRUCTION OF LOWER EXTREMITY [J].
Demirtas, Yener ;
Kelahmetoglu, Osman ;
Cifci, Mehmet ;
Tayfur, Volkan ;
Demir, Ahmet ;
Guneren, Ethem .
MICROSURGERY, 2010, 30 (01) :24-31
[42]   Free and pedicle flaps in lower extremity trauma [J].
Aho, Johnathon M. ;
Sen, Milan K. ;
Saint-Cyr, Michel .
EUROPEAN JOURNAL OF PLASTIC SURGERY, 2015, 38 (03) :171-182
[43]   Thin Perforator Flaps for Reconstruction of the Lower Extremity [J].
Ebner, Peggy J. ;
Gould, Daniel J. ;
Patel, Ketan M. .
JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2021, 37 (01) :5-11
[44]   Best Local Flaps for Lower Extremity Reconstruction [J].
AlMugaren, Faris M. ;
Pak, Changsik John ;
Suh, Hyunsuk Peter ;
Hong, Joon Pio .
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2020, 8 (04)
[45]   FASCIOCUTANEOUS FLAPS IN RECONSTRUCTION OF THE LOWER-EXTREMITY [J].
FIX, RJ ;
VASCONEZ, LO .
CLINICS IN PLASTIC SURGERY, 1991, 18 (03) :571-582
[46]   The role of flaps in preventing lower extremity amputations [J].
Felder, John M. ;
Nageeb, Emmanuel ;
Rocha, Ingrid ;
Qasawa, Ryan ;
Moltaji, Syena ;
Fuse, Yuma .
SEMINARS IN VASCULAR SURGERY, 2025, 38 (01) :64-73
[47]   Pedicled Peroneus Brevis Muscle Flaps as an Alternative to Fasciocutaneous Rotational Flaps for Lower-Extremity Soft Tissue Defects [J].
Antunez, Merlin ;
Huyen, Cormac ;
Neiman, Rafael .
JOURNAL OF ORTHOPAEDIC TRAUMA, 2024, 38 (03) :e105-e110
[48]   Lower Extremity Free Flaps for Breast Reconstruction [J].
Dayan, Joseph H. ;
Allen, Robert J., Jr. .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 140 (05) :77S-86S
[49]   MANAGEMENT OF CHRONIC OSTEOMYELITIS OF THE LOWER-EXTREMITY [J].
CHRISTIANO, RA ;
BOS, KE .
NETHERLANDS JOURNAL OF SURGERY, 1988, 40 (03) :76-79
[50]   Review of Antibiotics for Chronic Osteomyelitis of the Lower Extremity [J].
Greer, Natalie ;
Dekerlegand, Alaina ;
Schotting, Paul ;
Tracy, Morgan ;
Wells, Drew A. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S1386-S1387